Are GLP-1 Drugs a New Hope for Mental Health?

These days, it feels like everywhere you turn, people are talking about Ozempic.

Originally designed to help those with diabetes manage their blood sugar, GLP-1 drugs like Ozempic have gained serious media attention for their unexpected benefit—weight loss.

But the benefits of these drugs might go even further…

If you or someone you love has ever struggled with mental illness, you may be particularly interested in some of the latest research on GLP-1 receptor agonists. And before you brush this off as just another headline, recent studies show there’s real potential here for mental health benefits.

Dr. Riccardo De Giorgi, from Oxford University, is leading the charge in investigating the psychiatric potential of GLP-1 receptor agonists like semaglutide (Ozempic). Dr. De Giorgi recently presented his findings at the European College of Neuropsychopharmacology Congress and shared that GLP-1s might do more than just assist with blood sugar and weight management.

The drugs could hold promise for cognitive deficits, mood disorders, and even substance use issues.

GLP-1 drugs aren’t currently approved for psychiatric disorders, but researchers are looking closely at whether these medications could play a role in treating mental health conditions like depression and anxiety.

Dr. De Giorgi believes it’s time to stop thinking of these drugs solely as metabolic treatments and to start exploring their potential neuropsychiatric benefits.

What’s most intriguing is that GLP-1 drugs seem to show effects on mental health much earlier than weight loss even begins. And while we often try to separate physical and mental health benefits, researchers like Dr. De Giorgi argue that they shouldn’t be entirely disentangled. If these drugs help lower mortality in psychiatric patients, they’re already serving an important purpose, regardless of the exact mechanism.

In fact, research shows that individuals with severe mental illness (SMI) face disproportionately high rates of metabolic disorders like obesity and type 2 diabetes.

They also die 15-20 years earlier from cardiovascular disease than the general population. GLP-1 receptor agonists could have the potential to reduce that risk while offering cognitive and mental health benefits at the same time.

For those concerned about cognitive decline or mental health conditions, this new research could offer hope. GLP-1s may hold promise in addressing cognitive disorders such as dementia, including vascular dementia and frontotemporal dementia.

Early studies have also shown signals that these drugs may reduce substance use, especially nicotine misuse, and may have antidepressant properties as well.

We’ve discussed the cognitive benefits of GLP-1 drugs in a previous Health Sciences Institute newsletter, and this new research reinforces the importance of considering them for more than just diabetes or weight management. If you missed this newsletter article, you can find more on the cognitive potential of GLP-1s in our archives or access the newsletter here.

While the promise of GLP-1 drugs is exciting, there are natural ways you can support your mental and cognitive health right now. Ashwagandha, a powerful adaptogen, is known for its ability to reduce stress and improve mood, and studies show it can help with cognitive function.

Omega-3 fatty acids, found in fish oil, have long been hailed for their brain-boosting benefits and are known to improve mood and cognitive health over time.

These natural supplements, combined with lifestyle choices like a balanced diet and regular exercise, can provide meaningful support to your mental and cognitive well-being.

So while the world continues to watch GLP-1 drugs closely, know that you can take action now to protect your mind and body, with or without a prescription.

Looks like there’s more to Ozempic than just the headlines.

Stay sharp, stay curious,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

Johnson, K. (2024, September 24). Expert Calls for Research into GLP-1s for Mental Illness. Medscape; Medscape. https://www.medscape.com/viewarticle/expert-calls-research-glp-1s-mental-illness-2024a1000hbf